echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Study on Regulation of Hyperimmune Disease Related Gene CCL17

    Study on Regulation of Hyperimmune Disease Related Gene CCL17

    • Last Update: 2021-12-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Figure: A group of scientists from the University of Texas recently clarified the complex CCL17/TARC chemokine regulation pathway, revealing insights that can help us design new therapies for immune system-related diseases


    Source: https://pixabay.


    Allergies and many other types of immune system-related diseases originate from the interaction of complex chemical pathways that affect the behavior, distribution, and development of cells


    In order to solve this knowledge gap, a team of scientists from Japan conducted a detailed study.


    The team conducted a series of detailed experiments to clarify the relationship between CCL17, pu1 and other related transcription factors and promoters at the molecular level


    After using sirna to target PU.


    Through further cell culture experiments and computational analysis, the research team found that IRF4 and pu1 work together to activate the transcription of TARC in dendritic cells (copying DNA fragments into RNA) through the regulatory region of the CCL17 gene


    Finally, the scientists used an asthmatic mouse as a model to test the effect of pu1 inhibition in vivo


    These results highlight the importance of pu1 in inflammatory processes and immune diseases, and may pave the way for new treatments


    It is hoped that further research will help to further clarify the regulation and transcription pathways of CCL17, so as to have a more comprehensive understanding of the complex panorama of immune diseases


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.